[go: up one dir, main page]

Faff et al., 1978 - Google Patents

Increase in sensitivity to obidoxime induced by fluostigmine in the rat

Faff et al., 1978

Document ID
9154208274345056114
Author
Faff J
Bak W
Publication year
Publication venue
Toxicology and applied pharmacology

External Links

Snippet

The acute toxicity of obidoxime and its effects on neuromuscular transmission were studied in rats previously treated with atropine and fluostigmine. A single injection of atropine and fluostigmine (2 mg/kg sc) was given and then obidoxime was administered after 3, 24, 48, or …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A61K8/18—Cosmetic or similar toilet preparations characterised by the composition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
US5003098A (en) Method of reducing or eliminating adverse effects of a pharmaceutical composition or a drug
JP2528115B2 (en) Pharmaceutical composition containing inositol triphosphite
Kewitz et al. A specific antidote against lethal alkyl phosphate intoxication. II. Antidotal properties
Durham et al. Organic Phosphorus Poisoning and Its Therapy: With Special Reference to Modes of Action and Compounds Thai Reactivate Inhibited Cholinesterase
Jokanovic Structure-activity relationship and efficacy of pyridinium oximes in the treatment of poisoning with organophosphorus compounds: a review of recent data
Edwards et al. Effects of tricyclic antidepressants upon human platelet monoamine oxidase
DE3432094A1 (en) ESTER OF PYRIDINE-2,4- AND -2,5-DICARBONIC ACID AS A MEDICINAL PRODUCT FOR INHIBITING PROLIN AND LYSINE HYDROXYLASE
US5783584A (en) THA analogs useful as cholinesterase inhibitors
Matsumura et al. The enzymatic degradation of malathion in organophosphate resistant and susceptible strains of Musca domestica
Wilson et al. A specific antidote against lethal alkyl phosphate intoxication. V. Antidotal properties
Clement Efficacy of mono-and bis-pyridinium oximes versus soman, sarin and tabun poisoning in mice
Albert Mode of action of isoniazid
GB2223404A (en) The treatment of abnormal levels of lipoproteins.
Mengle et al. Insect Resistance to Insecticides, Biochemical Factors in the Acquired Resistance of Houseflies to Organophosphate Insecticides
US4002737A (en) Prevention and/or treatment of poison ivy dermatitis
US9884052B2 (en) Compounds and methods to treat organophosphorus poisoning
Faff et al. Increase in sensitivity to obidoxime induced by fluostigmine in the rat
DE2048375A1 (en) Making antibiotics effective
Bleiberg et al. Effects of certain metabolically active drugs and oximes on tri-o-cresyl phosphate toxicity
DE68914468T2 (en) Pantethin as a liver fibrosis inhibitor.
US4355027A (en) Process and composition for treating disorders by administering piracetam and choline
GB2056279A (en) Dermatological compositions containing alkaloids
US3928594A (en) Method of alleviating symptoms of multiple scleroisis
Harris et al. Reactivation of VX-inhibited cholinesterase by 2-PAM and HS-6 in rats
Davies et al. The antituberculous activity of ethyl thiolesters with particular reference to diethyl dithiolisophthalate